GlassScriptPhysician profile
Arsalan Hamid
NPI 1184253759
$587.37
in general payments reported to CMS, 2019-2025
9 companies · $571 in 2025
The $571 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.84 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $208.01 | 2025 | |
| Cvrx, INC. | $103.57 | 2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $103.01 | 2025 | Attruby |
| Boston Scientific Corporation | $55.64 | 2025 | Accolade Sr, Latitude Communicator Power Supply, General - Therapies |
| Medical Device Business Services, INC. | $42.75 | 2025 | Vistaseal |
| Lantheus Medical Imaging, INC. | $26.47 | 2025 | |
| Ethicon US, LLC | $17.41 | 2025 | Vistaseal, Stratafix, Surgicel Nu-Knit |
| E.R. Squibb & Sons, L.L.C. | $16.84 | 2023 | Eliquis |
| Pfizer INC. | $13.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arsalan Hamid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.